Welcome to our website for the Division of Rheumatology, Allergy and Immunology, the Department of Medicine, State University of New York (SUNY) at Stony Brook. Our Division is staffed by expanding faculty members, including six rheumatologists, one immunologist/professor, and one allergist, and the physicians are housed in both Stony Brook University Hospital (SBUH) and the VA Hospital at Northport.
Our tripartite missions are patient care, education and research. The goal of patient care is to take advantage of our expertise to provide high quality care for patients. Rheumatologists diagnose and treat a broad range of rheumatic diseases, such as systemic autoimmune, inflammatory, autoinflammatory diseases as well as musculoskeletal disorders. We take care of both common and rare rheumatic disorders. For example, we have a unique Multidisciplinary Center, one of the few centers in the country to deal with a recently categorized group of diseases, designated as autoinflammatory diseases or periodic fever syndromes. These diseases include but are not limited to Familial Mediterranean fever and NOD2-associated autoinflammatory disease. These patients usually have recurrent fever, rash, joint pain, abdominal or chest pain, and these symptoms often pose diagnostic and therapeutic challenges.
Our educational programs and services encompass training rheumatology fellows, medical residents and students. Our rheumatology fellowship program has existed since its inauguration in 1980. This is a two-year accredited clinical training program, and two fellows are chosen and recruited from a pool of applicants each year. There are four rheumatology fellows currently. The fellows participate in outpatient care and inpatient service in both Stony Brook University Hospital and VA Hospital at Northport. The fellows are provided opportunities to partake in performing clinical, translational or basic research projects. Our fellows have opted to practice in private and academic settings after graduation in the past. Our Division will also offer both online and live CME educational materials.
Our goal of research is to develop relevant research programs under current internal funding and to seek extramural funding to advance research of rheumatic diseases. NOD2-associated autoinflammatory disease (NAID) is an emerging inflammatory disease. Since our first report of the disease, we have found it not an uncommon disease. To continue shedding light into the disease, we will perform an in-depth study of its pathogenic mechanisms and develop effective therapies. Future funding opportunities, including grants and philanthropic donations, will be key and beneficial. The Division is also developing other research programs apart from ongoing research projects in our laboratory of the Division. These research projects will be conducted in a collaborative fashion.